Literature DB >> 20338932

Deciding against disability: does the use of reproductive genetic technologies express disvalue for people with disabilities?

Janet Malek1.   

Abstract

This paper focuses on one objection to the use of reproductive genetic technologies (RGTs): the argument known as the expressivist objection. According to this argument, the choice to use reproductive genetic technologies to prevent the birth of individuals with disabilities is an expression of disvalue for existing people with disability. Many have been persuaded by this impassioned perspective. This paper shows that this argument is misguided and so does not constitute a sound objection to the use of RGTs to prevent disability in future children. It first identifies some responses to the objection that may be sound but not completely convincing to proponents of the expressivist position. It then describes a thought experiment designed to demonstrate more clearly that choosing to use RGTs to prevent disability in future children does not convey a negative message about people who have disabilities. After describing a decision that clearly does not send such a message, the paper walks through a series of cases and shows how, despite differences that might seem to be morally relevant, each is morally equivalent to the previous one with respect to the extent that it expresses disvalue for such individuals.

Entities:  

Mesh:

Year:  2010        PMID: 20338932     DOI: 10.1136/jme.2009.034645

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  5 in total

1.  Public Perceptions of Ethical, Legal and Social Implications of Pre-implantation Genetic Diagnosis (PGD) in Malaysia.

Authors:  Angelina P Olesen; Siti Nurani Mohd Nor; Latifah Amin; Anisah Che Ngah
Journal:  Sci Eng Ethics       Date:  2016-12-19       Impact factor: 3.525

Review 2.  A systematic review of the views of healthcare professionals on the scope of preimplantation genetic testing.

Authors:  Maria Siermann; Zoë Claesen; Laurent Pasquier; Taneli Raivio; Olga Tšuiko; Joris Robert Vermeesch; Pascal Borry
Journal:  J Community Genet       Date:  2022-01-14

3.  Walking a Fine Germline: Synthesizing Public Opinion and Legal Precedent to Develop Policy Recommendations for Heritable Gene-Editing.

Authors:  Shawna Benston
Journal:  J Bioeth Inq       Date:  2022-04-19       Impact factor: 2.216

4.  Impairment Experiences, Identity and Attitudes Towards Genetic Screening: the Views of People with Spinal Muscular Atrophy.

Authors:  Felicity K Boardman; Philip J Young; Frances E Griffiths
Journal:  J Genet Couns       Date:  2017-06-30       Impact factor: 2.537

5.  CRISPR, a Crossroads in Genetic Intervention: Pitting the Right to Health against the Right to Disability.

Authors:  Shawna Benston
Journal:  Laws       Date:  2016-02-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.